Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Volkers

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1989
Comparison of two combined diuretics in the treatment of essential hypertensionW Verhiest, M Baehre, P Volkers
Pharmeuropa Bio|February 13, 2004
Control of Clostridium perfringens vaccines using an indirect competitive ELISA for the epsilon toxin component - examination of the assay by a collaborative studyU Rosskopf-Streicher, P Volkers, E Werner
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 15, 2005
[Regulatory aspects of clinical trials with emphasis on biologicals]P Volkers, S Poley-Ochmann, M Nübling
Vox Sanguinis|March 1, 2003
Validation of flow cytometry to quantify the potency of anti-D immunoglobulin preparationsG Schäffner, T Kayser, A Tönjes, et al.
Pharmeuropa. Special Issue Biologicals|November 14, 2001
Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1K Cussler, U Rosskopf-Streicher, P Volkers, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 31, 2013
[Special considerations for the regulation of biological medicinal products in individualised medicine. More than stratified medicine]J Müller-Berghaus, P Volkers, J Scherer, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|December 8, 2004
[Thiomersal and immunisations]K Weisser, K Bauer, P Volkers, et al.
Pharmeuropa Bio|February 3, 2007
Validation of in vitro potency assays for tetanus immunoglobulinS Gross, P Volkers, M Eckert-Ziem, et al.
Transfusion Medicine (Oxford, England)|August 3, 2004
Plasma quality after whole-blood filtration depends on storage temperature and filter typeM Heiden, U Salge, R Henschler, et al.
Vox Sanguinis|October 30, 2010
Monitoring bacterial contamination of blood components in Germany: effect of contamination reduction measuresG Walther-Wenke, C H Wirsing von König, W Däubener, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1989
Comparison of two combined diuretics in the treatment of essential hypertensionW Verhiest, M Baehre, P Volkers
Pharmeuropa Bio|February 13, 2004
Control of Clostridium perfringens vaccines using an indirect competitive ELISA for the epsilon toxin component - examination of the assay by a collaborative studyU Rosskopf-Streicher, P Volkers, E Werner
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 15, 2005
[Regulatory aspects of clinical trials with emphasis on biologicals]P Volkers, S Poley-Ochmann, M Nübling
Vox Sanguinis|March 1, 2003
Validation of flow cytometry to quantify the potency of anti-D immunoglobulin preparationsG Schäffner, T Kayser, A Tönjes, et al.
Pharmeuropa. Special Issue Biologicals|November 14, 2001
Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1K Cussler, U Rosskopf-Streicher, P Volkers, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 31, 2013
[Special considerations for the regulation of biological medicinal products in individualised medicine. More than stratified medicine]J Müller-Berghaus, P Volkers, J Scherer, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|December 8, 2004
[Thiomersal and immunisations]K Weisser, K Bauer, P Volkers, et al.
Pharmeuropa Bio|February 3, 2007
Validation of in vitro potency assays for tetanus immunoglobulinS Gross, P Volkers, M Eckert-Ziem, et al.
Transfusion Medicine (Oxford, England)|August 3, 2004
Plasma quality after whole-blood filtration depends on storage temperature and filter typeM Heiden, U Salge, R Henschler, et al.
Vox Sanguinis|October 30, 2010
Monitoring bacterial contamination of blood components in Germany: effect of contamination reduction measuresG Walther-Wenke, C H Wirsing von König, W Däubener, et al.
Pageof 2